Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment
PREVAPA
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
This is a non-randomized, non-controlled feasibility study which will take place at the Besançon University Hospital in the conventional hospitalization department. It will be carried out with patients hospitalized in the conventional hospitalization department of the medical oncology department of Besançon University Hospital. At entry, after presenting the study and obtaining non-opposition from patients, an initial assessment will be carried out before the APA program. This assessment will include an evaluation of physical parameters (measurements of body composition, functional capacities, autonomy in activities of daily living and muscular strength), as well as an evaluation of quality of life relating to health and motivation to practice physical activity. At the end of the initial assessment, an APA program supervised (individually and in a room) by an APA teacher will be offered to patients. The sessions will be offered daily to patients (maximum 5 times/week). They will last on average 20 minutes each depending on the fatigue, pain and fitness of the patients. The objectives pursued are mainly an improvement in functional independence and mobility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Mar 2024
Shorter than P25 for not_applicable cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 20, 2024
December 1, 2023
9 months
March 7, 2024
March 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validate the feasibility of a supervised adapted physical activity (APA) program during the first 7 days of hospitalization in medical oncology for patients with cancer undergoing treatment
The main objective of the study is to validate that the proportion of patients having completed, from inclusion (D0), at least three supervised APA sessions of a minimum duration of 15 minutes, during the first 7 consecutive days of his hospitalization (P) is beyond a threshold considered uninteresting of 50% (P0) To test the following hypotheses: H0: a compliant patient rate \<= 50% is uninteresting (P\<=P0) H1: a compliant patient rate \> 80% is expected (P\>P1) With an A'Hern type design, a one-sided alpha risk of 2.5% and a power of 90%, it is required to include 28 evaluable patients in the study to test H0 vs H1. Considering a rate of unevaluable patients of 10% it will be necessary to include 32 patients. Hypothesis H0 will be rejected if 20 (71.4%) or more than 20 patients out of the first 28 evaluable are compliant.
7 days after inclusion
Secondary Outcomes (12)
Describe the evolution of body composition measured by impedancemetry
At inclusion (day 1) and at the study completion, an average of 15 days
Describe the evolution of physical parameters functional capacities
At inclusion (day 1) and at the study completion, an average of 15 days
Describe the evolution of autonomy in daily life activities
At inclusion (day 1) and at the study completion, an average of 15 days
Describe the evolution of muscular strength
At inclusion (day 1) and at the study completion, an average of 15 days
Describe the evolution of the quality of life
At inclusion (day 1) and at the study completion, an average of 15 days
- +7 more secondary outcomes
Study Arms (1)
Adapted physical activity program (APA Program)
EXPERIMENTALAn intervention (APA program) will be offered to patients hospitalized in the conventional hospitalization department of the medical oncology department. At entry, after presenting the study and obtaining non-opposition from patients, an initial assessment will be carried out before the APA program. At the end of the initial assessment, an APA program supervised (individually and in a room) by an APA teacher will be offered to patients. The sessions will be offered daily to patients (maximum 5 times/week). They will last on average 20 minutes each depending on the fatigue, pain and fitness of the patients. The objectives pursued are mainly an improvement in functional independence and mobility.
Interventions
Content of the APA program: * Strengthening of the lower limbs: Exercises alternating different regimes of muscular contractions (eccentric, concentric and isometric), with the use of elastics, balls or even body weight. These exercises will mainly work the quadriceps and hamstrings. * Upper limb strengthening: Exercises focused on eccentric and concentric contraction regimes, in a global movement approach (as opposed to a segmental approach), with the use of elastics, dumbbells, weighted balls, etc. These exercises will work the muscles of the biceps, triceps, pectorals, deltoids and lats. * Walking: In the room and/or in the corridor, with technical assistance (cane/walker, etc.) or human work * Balance and proprioception: Balance work in a bi- and uni-pedal situation, statically and dynamically (eyes open and closed) will be offered with the use of proprioception boards and/or mats combining if possible work in dual task.
Eligibility Criteria
You may qualify if:
- Man or woman aged 18 and over (no age limit)
- Patient followed for cancer,
- Patients with no medical contraindication to adapted physical activity (certificate)
- Patient with a performance index status less than 4
- Patient hospitalized in the conventional medical oncology hospitalization department of Besançon University Hospital.
- Patient not opposed to participating in the study
- Patient affiliated to a French social security scheme or beneficiary of such a scheme.
- For women: menopausal for at least 24 months, surgically sterilized, or, for women of childbearing age, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, patches contraceptives)
- Length of hospitalization estimated at at least 7 days (main objective) and with the patient's objective of returning home or to SSR in the long term
You may not qualify if:
- Patient with an absolute medical contraindication to adapted physical activity
- Patient with inability to understand instructions and complete questionnaires.
- Patient with a performance index status of 4
- Patient with legal incapacity or limited legal capacity
- Patient unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
- Patient without health insurance
- Pregnant woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Quentin JACQUINOT, Dr
CHU Besançon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 20, 2024
Study Start
March 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
March 20, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share